UK takes steps to speed up patient access to new treatments in hospitals
This article was originally published in SRA
The UK’s health technology assessment body, the National Institute for Health and Clinical Excellence, together with the Department of Health, has proposed new measures to speed up patient access to new health technologies under the government-funded National Health Service1. This includes a consultation on proposed changes to the way that topics (covering pharmaceuticals, biopharmaceuticals, devices and diagnostics) are chosen and referred for NICE’s appraisals of new drugs and treatments2.
You may also be interested in...
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-four guidance documents have been posted on the tracker since its last update.
The risk of psychiatric disorders with chloroquine and hydroxychloroquine-containing medicines received renewed attention in the EU after they were being used as potential treatments for COVID-19.